Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
4.56M
-
Number of holders
-
120
-
Total 13F shares, excl. options
-
93.3M
-
Shares change
-
+17.6M
-
Total reported value, excl. options
-
$1.6B
-
Value change
-
+$283M
-
Put/Call ratio
-
0.63
-
Number of buys
-
92
-
Number of sells
-
-20
-
Price
-
$17.13
Significant Holders of RECURSION PHARMACEUTICALS, INC. - Common Stock (RXRX) as of Q4 2021
135 filings reported holding RXRX - RECURSION PHARMACEUTICALS, INC. - Common Stock as of Q4 2021.
RECURSION PHARMACEUTICALS, INC. - Common Stock (RXRX) has 120 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 93.3M shares
.
Largest 10 shareholders include BAILLIE GIFFORD & CO (22.1M shares), BlackRock Inc. (6.76M shares), VANGUARD GROUP INC (6.11M shares), Obvious Management Services, L.L.C. (5.98M shares), Data Collective IV GP, LLC (5.94M shares), STATE STREET CORP (4.66M shares), DCVC Opportunity Fund II GP, LLC (3.95M shares), Laurion Capital Management LP (3.92M shares), ALLIANCEBERNSTEIN L.P. (2.88M shares), and ARK Investment Management LLC (2.23M shares).
This table shows the top 120 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.